Explaining Costs of Pediatric Cancer Chemotherapy Admissions
April 26, 2016 | Vivian Ho
Table of Contents
Author(s)
Vivian Ho
James A. Baker III Institute Chair in Health EconomicsBy Vivian Ho, Heidi Russell and Andrew Street
State-based Medicaid programs have begun using All Patient Refined–Diagnosis-Related Groups (APR-DRGs) to determine hospital reimbursement rates. This study examined how well APR-DRGs reflect admission costs for childhood cancer chemotherapy to inform clinicians, hospitals and policymakers in the wake of policy changes.
Read the full article in the Journal of Oncology Practice (subscription required).